IMPROVED SURVIVAL DURATION WITH COMBINATION CHEMOTHERAPY INDUCTION FOR MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：87
|
作者：
DURIE, BGM
DIXON, DO
CARTER, S
STEPHENS, R
RIVKIN, S
BONNET, J
SALMON, SE
DABICH, L
FILES, JC
COSTANZI, JJ
机构：
[1] UNIV ARIZONA,ARIZONA MED CTR,TUCSON,AZ 85724
[2] SW ONCOL GRP,CTR BIOSTAT,HOUSTON,TX
[3] UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103
[4] PUGET SOUND ONCOL CONSORTIUM,SEATTLE,WA
[5] SCOTT & WHITE CLIN,TEMPLE,TX
[6] UNIV MICHIGAN,ANN ARBOR,MI 48109
[7] UNIV MISSISSIPPI,MED CTR,JACKSON,MS 39216
[8] UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 08期
关键词：
D O I：
10.1200/JCO.1986.4.8.1227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1227 / 1237
页数：11
相关论文
共 50 条
  • [41] IMPROVED SURVIVAL IN MULTIPLE-MYELOMA WITH RENAL-FAILURE
    WAHLIN, A
    LOFVENBERG, E
    HOLM, J
    ACTA MEDICA SCANDINAVICA, 1987, 221 (02): : 205 - 209
  • [42] IMPROVED LONG-TERM SURVIVAL IN MULTIPLE-MYELOMA
    PALVA, IP
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (05) : 385 - 388
  • [43] CORTICOSTEROID IS NOT BENEFICIAL IN MULTIPLE-DRUG COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA
    PALVA, IP
    ALAHARJA, K
    ALMQVIST, A
    ELONEN, E
    HALLMAN, H
    HANNINEN, A
    ILVONEN, M
    ISOMAA, B
    JOUPPILA, J
    JARVENPAA, E
    JARVENTIE, G
    KILPI, H
    KOISTINEN, P
    KOIVUNEN, E
    KATKA, K
    KAARIAINEN, M
    LAHTINEN, R
    LAITINEN, A
    LEHTINEN, M
    MAKELA, H
    NYLANDEN, P
    NYMAN, D
    OIVANEN, T
    PELLINIEMI, TT
    PULLI, T
    RAJAMAKI, A
    REMES, K
    ROSENGARD, S
    RUUTU, T
    SOININEN, K
    TIMONEN, T
    WASASTJERNA, C
    VILPO, J
    VOLIN, L
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (02) : 98 - 101
  • [44] ADRIAMYCIN AND COMBINATION CHEMOTHERAPY IN BREAST-CANCER - SOUTHWEST ONCOLOGY GROUP STUDY
    HOOGSTRATEN, B
    GEORGE, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 70 - 70
  • [45] COMBINATION CHEMOTHERAPY FOR MYCOSIS-FUNGOIDES - SOUTHWEST-ONCOLOGY-GROUP STUDY
    GROZEA, PN
    JONES, SE
    MCKELVEY, EM
    COLTMAN, CA
    FISHER, R
    HASKINS, CL
    CANCER TREATMENT REPORTS, 1979, 63 (04): : 647 - 653
  • [46] Evaluation of topotecan in resistant and relapsing multiple myeloma: A Southwest Oncology Group Study
    Kraut, EH
    Crowley, JJ
    Wade, JL
    Laufman, LR
    Alsina, M
    Taylor, SA
    Salmon, SE
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 589 - 592
  • [47] COMBINATION CHEMOTHERAPY (MOPP) IN MULTIPLE-MYELOMA - PRELIMINARY-REPORT
    DUBOVSKY, D
    KING, HS
    VIOLETT, L
    JACOBS, P
    SOUTH AFRICAN MEDICAL JOURNAL, 1977, 52 (17): : 692 - 693
  • [48] MULTIPLE-MYELOMA - INTERMITTENT, COMBINATION CHEMOTHERAPY COMPARED TO CONTINUOUS THERAPY
    GEORGE, RP
    SCHRIER, SL
    GORDON, D
    POTH, JL
    CANCER, 1972, 29 (06) : 1665 - +
  • [49] IMPROVED COMPLETE REMISSION RATES AND SURVIVAL FOR PATIENTS WITH LARGE CELL LYMPHOMA TREATED WITH CHEMO-IMMUNOTHERAPY - A SOUTHWEST ONCOLOGY GROUP-STUDY
    JONES, SE
    GROZEA, PN
    METZ, EN
    HAUT, A
    STEPHENS, RL
    MORRISON, FS
    TALLEY, R
    BUTLER, JJ
    BYRNE, GE
    HARTSOCK, R
    DIXON, D
    SALMON, SE
    CANCER, 1983, 51 (06) : 1083 - 1090
  • [50] GALLIUM NITRATE IN MALIGNANT-LYMPHOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    WEICK, JK
    STEPHENS, RL
    BAKER, LH
    JONES, SE
    CANCER TREATMENT REPORTS, 1983, 67 (09): : 823 - 825
12345